Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Chris Cleary Right above the M&A Attorney’s Signature
Medtronic has a history of placing large bets on technology that must go through the FDA’s stringent pre-market approval program, then basking in massive returns on those bets by assuming a market leadership position once the product wins PMA, Cleary explained, pointing to Medtronic’s acquisition of CoreValve as a prototypical Medtronic move.
Chris is Vice President of Corporate Development for Medtronic, with responsibility for acquisitions, dispositions and minority investments. During 2014, Chris led the corporate development efforts for Medtronic’s $50B acquisition of Covidien as well for Medtronic’s acquisition of both Sapiens and NGC, for $200MM and $350MM respectively.
Priorto 2014, Chris was CEO of Alesia Capital Services, a management consulting firm for Fortune 500 companies, including Medtronic, Goldman Sachs, Ally, Macquarie Capital and Terex. From 1995 to 2011, Chris led M&A teams within several businesses at GE Capital, closing acquisitions totaling more than $60B across 200+ transactions in the US, Canada, Europe, Asia and Latin America.
https://www.massdevice.com/inside-medtronic-covidien-deal-contrasting-styles-brought-companies-together/
PuMper Dumper
You lie, cheat and steal to this board be gone for ever in Jesus Name Amen
TMDI FOR THE WIN
In what way is Titan disruptive?
We are developing a robotic surgical system that is differentiated and creative to truly enable the breadth of procedures possible through single access surgery. We have a pipeline of innovation covering a spectrum of technologies that we hope to introduce over the coming years. By placing early systems in the hands of expert surgeons, we have been able to incorporate the learnings from their operations in preclinical and laboratory testing environments into our subsequent developments.
We may be a small company, but we pride ourselves in our innovation. The feedback we have received from various market participants, including established medical device companies, has been positive.
On a more personal note: what fascinates you about your work?
I love working with the energetic and talented people on my team. I am motivated by this team and enjoy the deeply technical collaborative culture we have created here and the alignment and commitment to Titan Medical’s vision. It is, after all, a team sport, and this is a great team focusing their immense talents on a great mission. While I am an engineer at heart and I love technical challenges, I feel that my role here is focused on mentoring, teaching, and encouraging the group to achieve important and relevant product development milestones. Rarely does one get the opportunity to do something so big, unique, and bold that will have such an impact on humanity.
And it is a lot of fun – We are a solid business, we are well funded, we have great foundational technology, and we have a pathway to build a successful commercial presence, providing the market with an attractive alternative to what is currently available.
ENOS - Einstein Operating System
https://jobs.medtronic.com/jobs/senior-principal-robotics-surgery-start-up-specialist-100970
Career that change lives
The Project Einstein Customer Operations team manages all aspects of system installation, start-up, customer training, field service analysis and support, and program optimization. Placement of a surgical robot in the hospital requires full time support for a four to eight-month period in order to ensure successful integration into the hospital’s service lines. Project Einstein Customer Operations team members are seasoned professionals with in-depth knowledge of the healthcare value chain, as well as breadth of experience across multiple disciplines. They partner with hospital management teams and payers to drive complex transformational change, implement innovative growth strategies, streamline patient-focused care pathways and optimize operations.
A day in a life
Medtronic is in the process of rolling out its robotic surgery platform. In that context we are looking for a seasoned operational transformation expert. You will be responsible for successful integration of a new surgical robot into a hospital.
This might be an expansion of a current robotic surgery program, creation of a new robotic surgery program, or a changeover from a competitive robot to the Medtronic robot.
Activities to integrate the Medtronic robot include training the hospital to clean and sterilize reusable instruments, arranging the off-site training of surgeons and supporting staff, updating surgeon preference cards, developing an inventory plan and kits for robotic procedures, raising awareness of robotic surgery, and helping to schedule the use of the robot. These activities would happen over a four to eight-month engagement. At the end of the engagement, the hospital should be on track to hit utilization targets before turning over the program to the sales team.
Additional post integration visits to help the hospital improve performance of their robotic surgery program, optimize resources and asset utilization.
You would be the first Robotic Surgery Start-Up Specialist, piloting its execution and preparing its broadcasting and wider commercialization outside the launch country and region.
Main Responsibilities
Meet with the Director of Robotic surgery and develop program goals and metrics for the Medtronic robot
In concert with the Medtronic Field Service Engineer and the hospital staff, prepare the operating room to host the Medtronic robot
Train hospital staff to clean and sterilize re-usable robotic instruments
Develop a surgeon training plan, schedule attendance at Medtronic’s off-site training, arrange for proctored cases post-training
Develop a training plan for support staff to include attendance at a Medtronic off-site training class and working with staff post training through learning curve
Conduct regular program review meetings with the hospital’s Director of Robotic Surgery
Support the technology adoption by attending most if not every case during a surgeon and staff member’s learning curve
Utilize change management techniques to engage clinical stakeholders and attain buy-in
Train and coach Hospitals’ staff to promote skill transfer and achieve self-sufficiency in operational excellence
Generate clear proof points of the value delivered for pilot site by such program
Package the service program developed and support its commercial deployment across hospitals
Key areas of expertise are:
Project / program management skills,
Relationship building / customer engagement skills,
Operating Room knowledge, Consultancy expertise,
Change management skills
As part of the Project Einstein Customer Operations team, you should be able to:
Work independently, yet in close relationship with its customer, propose and implement innovative approaches
Help prepare the Medtronic sales representative responsible for the account to take over day to day management of the relationships at the end of the engagement
Share and communicate determined best practices actively in the team
Work together as a team to develop new service offerings out of pilot projects for wider deployment
Computing and Healthcare
Robotics and Surgery
Biggest Pockets In the World Investing
Great things ahead for the industry as a whole
Sure glad we’ve got the best name in healthcare backing us
A computer geek can sure raise some noise.... only a positive for all the major players as a whole....brings awareness, deep pockets, and a world of new eyeballs
Forbes toting Bill Gates in the first sentence
https://www.google.com/amp/s/www.forbes.com/sites/amyfeldman/2021/07/28/vicarious-surgical-bill-gates-backed-fantastic-voyage-inspired-miniature-surgical-robot-aims-to-revolutionize-abdominal-surgery/amp/
it’s honestly tough to fathom a stock going from .25 cents to 25.00 or higher however it happens on the OTC when you see a .0001 run to 1.00 or higher
Robotics got me into investing over 15 years ago every investment I’ve made has gone up ...this has been a 10 year train wreck but like you stated I have averaged down and I’m up 100% on my investment to date
Anyone on the fence has to understand the value of a patent, a partnership, market share and technology disruption on the economy of scale
Since our partnership has been made public with MDT we have almost doubled the amount of patents issued by the USPTO
Since our partnership with MDT we have seen our share price go from .25 to 3.00+ or higher
I don’t see us going anywhere other then up, anyone who is saying otherwise has another agenda at play
Lessss gooooo tit...... longs we gonna make Vegas really happen when this comes to light??? I’m in if we do
Who’s smarter then Medtronic???
Lesssssss Goooooooooooo TIT
I’m not impressed with this new cfo, cipher nasdaq delisted ... normal day at wtf by the day
Another Up DAY AT TITANVILLE
Turn it down you say
But all I got to say to you is time and time again I say No!
No! No! No!
Tell me not to play
Well, all I got to say to when you tell me not to play I say No!
No! No! No!
Investinthefuture please tell me your still long and strong
hope your doing well ....
Intellectual property (IP) often represents one of the largest asset classes that a company holds, and unlocking its value is a key element in any business sale. The value of intellectual property such as patents, trademarks, brands, databases, and trade secrets, can be valued using a number of methodologies.
But what makes these intangible assets so valuable to a business?
Registered patents and designs prevent competitors from launching similar, competing products and potentially pushing the business aside within the market.
Holding the rights to a product design enables a company to make a unique offering to their market, and price their products accordingly.
The company’s position and profile as an innovative business can be boosted.
For design-only businesses, the license for their IP, used by third parties to manufacture and sell their product(s), provides a significant and valuable income stream.
Essentially, intellectual property assets can increase revenue or reduce business costs, and when they generate an income for the business being sold, a number of valuation methods can be utilized.
There is no particular method of valuation that is suitable for every business sale, however – the most appropriate one depends on a number of factors, including whether the intellectual property rights (IPR) are fully developed and functioning,
Cost-Based Valuation Method
The cost method uses the costs incurred by the business in the creation and development of their IPR. It also takes into account the potential cost of recreating such an IP asset or developing a product that is similar in nature.
These costs might include:
Research and development
Equipment and materials
The cost of labor
Prototype creation
Trialing and testing the product
Obtaining approval and certification from the relevant regulatory bodies
Registration of the intellectual property
Overheads with regards to utilities, accommodation and support staff
The concept behind the cost method of valuation is that a business purchaser would not have to incur these costs if they buy the IPR. Furthermore, in doing so they would not have to suffer the financial and/or operational consequences of failing to successfully develop their own IPR, or deal with the potential difficulties in protecting it if they did develop their own.
One of the downsides of this method of valuation is that potential future profits are not incorporated into the calculation – it is based solely on the costs incurred, which does not take account of possible future success in the marketplace.
Income-Based or Economic Benefit
Valuation Method
The income method of IP valuation, also known as the economic benefit method, aims to identify the income that a company’s intellectual property rights could generate in the future, and the costs of generating that income – in other words, the economic benefit to the business over the IP’s useful economic life.
Figures for risk and the financial cost are also calculated and included in the overall calculation, the result is what is known as the Net Present Value, or NPV. A prospective buyer can use this figure to help them make their purchase decision, which would depend on whether the NPV is positive or negative.
In contrast to the cost method, the income method uses potential future scenarios as the basis for the valuation, rather than past events. This in itself can cause issues given the difficulty in forecasting over a period of several years, and also in calculating the useful economic life of IP assets.
Factors which may be taken into account include:
State of the economy
The extent of the IPR’s market
The type of competition
Costs such as registering and defending the intellectual property
A secondary form of the income/economic benefit method is relief from royalties, whereby a value can be assessed based on how much money in royalties the company would have to pay if they didn’t own their intellectual property assets outright.
Market-Based Valuation Method
The market value method uses a product’s performance in the market to arrive at a valuation. Transactions involving similar products are also used for comparison purposes. Again, this method of valuation has pros and cons.
Market value offers a relatively reliable valuation basis, is based on supply and demand in the marketplace, but when it comes to comparison with other products there is not a great deal of information publicly available.
This type of data often remains confidential, and any that is readily available tends to be general in nature. If suitable transactions are found, a further difficulty can arise if the context of the transaction is something other than a business sale – insolvency, for example, or litigation. In this case, an adjustment would need to be made in order to allow for more accurate comparison of IPRs.
If appropriate data is available, however, the market approach is generally considered to be a fair method of valuing IP assets as it takes into account consumer behavior.
The ownership of intellectual property rights can considerably enhance the value of a business, but the most appropriate method of valuing IPRs will vary between companies. An understanding of the economy, the industry in which the business operates, and the business itself, are all required to arrive at a fair value figure.
PLI Patent Bar
Mazor Robotics Signs Strategic Commercial and Investment Agreements With Medtronic, a Global Leader in Spine Technologies and Solutions
https://www.businesswire.com/news/home/20160518005367/en/Mazor-Robotics-Signs-Strategic-Commercial-and-Investment-Agreements-With-Medtronic-a-Global-Leader-in-Spine-Technologies-and-Solutions
Logan Frederick interesting very very interesting
https://www.linkedin.com/in/logan-frederick-54125317a
EXB Solutions
https://exbsolutions.com/our-clients/?gclid=EAIaIQobChMIjfDVydu98QIVcm5vBB2GNwijEAAYASADEgI8dvD_BwE
And the plot thickens.......
Thanks Roll for posting the newest video .........
the share price has the opportunity to impact humanity and the worlds largest medical device company has given this little engine that could 40 million reasons to believe it
Enos and Ottovo and Hugo Oye Vey
Endolumin is the MDT/TMD next robot in line That has the opportunity to impact humanity
Alphabet’s Verily is pursuing surgical robotics with renewed intensity and is in talks with Johnson & Johnson for a lucrative new deal
Verily and Johnson & Johnson had previously partnered on a surgical robots venture, but Verily sold its stake in 2019. The company has since been building a technology for surgical robots, these people said. They asked not to be named because they were not permitted to talk to the press.
The technology was described as an advanced video laparoscope that would work with other surgical tools as part of a robotic system. This camera would use Verily’s software and machine learning technologies to improve minimally invasive surgeries, these people said.
Verily demoed its new technology to Johnson & Johnson this month in the hopes of sparking what could be a highly lucrative new revenue stream, they said.
https://www.google.com/amp/s/newsnationusa.com/news/finance/banking/alphabets-verily-is-pursuing-surgical-robotics-with-renewed-intensity-and-is-in-talks-with-johnson-johnson-for-a-lucrative-new-deal/amp/
MDT/Google/Titan
1.77 she’s a climbing!!!!!
1.64 she’s a climbing!!!!!
When a marriage is broken and neither party takes action it doesn’t change that the marriage is broken
Titan is engaged to Medtronic the world’s largest medical device in the world- the world’s largest medical device company put 40 million into the engagement party
Can’t wait for the wedding
Hashtags LONG AND STRONGERS
LESSSSSSSS GOOOOOOOO TIT
Consumables Brilliant
KarlStorz IREP TITAN Medtronic Fowler
https://pdfaiw.uspto.gov/.aiw?Docid=20210177536&homeurl=http%3A%2F%2Fappft.uspto.gov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%2526Sect2%3DHITOFF%2526p%3D1%2526u%3D%25252Fnetahtml%25252FPTO%25252Fsearch-bool.html%2526r%3D1%2526f%3DG%2526l%3D50%2526co1%3DAND%2526d%3DPG01%2526s1%3D%252522titan%252Bmedical%252522%2526OS%3D%252522titan%252Bmedical%252522%2526RS%3D%252522titan%252Bmedical%252522&PageNum=&Rtype=&SectionNum=&idkey=AB0C1FFCD795
Honey bunny we’re a loyal long bunch of folk your games don’t work round these parts
Lessssss Gooooooooooooooo TIT
Love me some “[Redacted]”PROTOTYPE Deliverables
Due some due diligence for ole Dilly
I can count 22 times this document goes
Over an MDT / TMDI PROTOTYPE
sec.report/Documents/0001157523-20-000865/
I’m gonna apologize upfront live......your constant banter like you have any idea what you know what your talking about other then vomiting this board with the same rant over and over again... makes me sick... usmart .... godbless ... sorry but I only get one post a day and I wish you had less
I have eluded to a JNJ and Titan acquisition prior to MDT based on a lot of unique coincidences that clearly may have been wrong...
However I am convinced that a partnership with MDT JNJ and TMDI between their technologies, assets, and intellectual property could be an important opportunity interest to takeover a billion dollar robotic surgery sector that has been owned independently by one player... its absolutely not out of the question.. ask yourself if Tesla inventions were independent or a betterment to the many..
When have you seen two power house corporations play nice in the sand box?
When it’s in both party’s best intersects....
Honda and Ford are a perfect example both funding a technology that will exponentially impact their footprint in autonomous self driving cars with in the next four years
I believe their is more to meet the eye here... let’s not forget the founder and KarlStorz...Longs let’s not forget Hargrove and his ties with Military and JNJ and once quoted as saying this isn’t a once in a lifetime play this will be multigenerationally rewarding
Sharing is caring, thank you!
How old is this video? Where did you find it Benzinger?
This has been an 8+ year roller coaster of emotions and I’m feeling that rush of excitement for the 50th time again
Lesss gooooooooooooo TIT
What’s with all the negativity didn’t we just get 10 million reasons from the worlds largest medical device company we are on a path to greatness???
Sport19 did say he’s back in and he think it’s headed higher
I agree, we’re headed for greatness
Hashtag PatentPending4Life
We KNOW WERE A 2 HEADED MoNster Right Now
ENOS
HUGO
Anyone notice when you google Medtronic Hugo CE Submission 2nd Result on Google?
Ole Buddy Ole Pal
https://www.ximedica.com/surgical-robotic-platform-development?gclid=EAIaIQobChMIvLyw6rf68AIVlklyCh2VNgs3EAAYAiAAEgJ9r_D_BwE
Could we be a 3 Headed Monster Titan/Medtronic/JNJ????
I agreee Sport is headed for snake army greatness.... les goooooooo TIT
Any chance Hugo acts as titans Predicate Device ???
A predicate device (PD) is a medical device that may be legally marketed in the U.S, and used as a point of comparison for new medical devices seeking approval through FDA's 510(k) premarket clearance pathway.
McNally confirmed later this month right?
I thought I read somewhere end of may.....
Lessssss goooooooo tit
I got the kernels soaking in OIL it’s about to get POPPIN IN VIVA LAS VEGAS
NOTICE OF ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS AND MEETING CONTENT
Date: June 9, 2021
Time: 4:00 p.m. ET
Link: https://web.lumiagm.com/433539983
username: click “I have a login”
and enter your control number
password: “titan2021” (case sensitive)
The business of the Meeting will be to:
1. receive and consider the financial statements of the Company for the fiscal year ended December 31, 2020, together with the report of the auditors thereon;
2. elect directors of the Company for the ensuing year;
3. appoint as auditors BDO Canada LLP, the incumbent auditors of the Company, and authorize the directors to fix the remuneration of the auditors;
4. approve the renewal of the Company’s stock option plan;
5. approve amendments to the Company’s stock option plan to permit the Company to designate up to a maximum number of options granted to be incentive stock options (ISOs) under Section 422 of the United States Internal Revenue Code; and
6. transact such other business as may properly come before the Meeting or any adjournments thereof.
The Meeting will take place via live webcast online at
https://web.lumiagm.com/433539983 on June 9, 2021 at 4:00 p.m. ET.
DATED May 13, 2021.
By Order of the Board
(signed) “Paul Cataford”
Chairman of the Boa
https://d1io3yog0oux5.cloudfront.net/_4ba727e3312b1d74b9051823196e162b/titanmedicalinc/db/1153/9843/pdf/Titan+Medical+MIC+2021.pdf
It’s inevitable everytime I add we go down added 1k shares at 1.69.....
Big Names at Vicarious Just Solidifies the brightest minds see surgical robotics as a great place to park their cash for ROI
Lesssss goooooo tit
Hell Yah!!!!! Worlds largest medical device company has 40 million reasons to believe cell good luck to your pal we’re headed to the moon
There’s some moanin and groanin...
There’s some pumpin and dumpin....
Heck theirs some hate’en and appreciate’en .....
I’m a fan of 40 million dollar investments from reputable medical device companies ....
I’m a fan of monthly intellectual property that secures market share and revenue in decades to come...
I’m a fan of more cash on hand then the last 8 years of my investment ....
Heck I’m a fan of this board and the mother truckers that won’t sell a share but bring constant feedback and information that is not on the public radar....
Not so much of a fan of the QQQ talk or of a 17 yr old pumpin Titan but I’ll take it wake ....
Hoping for some St Patrick’s Fireworks.... lesssss go Tit....
Ps I scooped at 2.60 normal day of my timing ....
$19 By May
We are the world we are the children
Belize dat
https://titanlivinglabs.com/enos/?unapproved=1&moderation-hash=fe65ce325c332e3aa1b5412cc31740fa#comment-1
Ukdesignstv@gmail.com??
https://titanlivinglabs.com/welcome/
At Titan Living Labs, we’re solving the problems facing robotic single access surgery—robotic assisted surgery through one entry point. We’re charting the path toward endoscopic surgery that delivers cost benefits and better health outcomes.
Check back for frequent updates.
I played this all wrong .... good luck to all a 500 Investment over 8 years ago netted 6k if I was smart I would of netted 50k good luck to all here I’m out
What’s the password!!!
What website!?
What is this the conference call number?
Can you post the conference call number to dial?
Thier not holding a press conference with out a game plan this is just getting good
FLY, ROCKO, BigT, Flenderson, Roll
What are your thoughts on CPUH?????
The company is led by Chairman Omar Ishrak, who currently serves as the Chairman of Intel (Nasdaq: INTC) and previously served as CEO of Medtronic. He is joined by Co-CEO and Director Jean Nehmé, who co-founded Digital Surgery in 2011, and Co-CEO and Director Joshua Fink, who is the Managing Partner of private investment company Ophir Holdings. Compute Health Acquisition intends to focus on opportunities that are emerging at the intersection of computation and healthcare, with a particular focus on how data access, artificial intelligence, algorithms, and computational power feed innovation in the healthcare industry.
The Company is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company intends to focus on healthcare businesses that are already leveraging, or have the potential to leverage, computational power, with an emphasis on companies in the medical device space, including imaging and robotics, and companies operating in the virtual care space, including telehealth, care delivery and next-generation payor and provider models.
Medical device company Medtronic and the Public Investment Fund of Saudi Arabia had indicated on an aggregate 9 million units in the offering.